HRSA Revises RWHAP Policy Notice on Eligibility Determinations
In October 2021, HRSA's HIV/AIDS Bureau revised its client eligibility and recertification policy for the Ryan White HIV/AIDS Program.
In October 2021, HRSA's HIV/AIDS Bureau revised its client eligibility and recertification policy for the Ryan White HIV/AIDS Program.
Ten fact sheets on client populations getting care from the Ryan White HIV/AIDS Program (RWHAP) a
In the U.S., almost all people with HIV have some type of health insurance coverage (pub
Resource (Conference Presentation) updated 09/14/2023
Blog updated 10/04/2022
Blog updated 06/30/2022
Blog updated 08/19/2022
Resource updated 10/05/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 02/21/2024
Resource (Conference Presentation) updated 09/14/2023
By cross matching registries of HIV and other sexually transmitted infections, this study found 27.1% of male syphilis cases were coinfected with HIV and 31.8% of those coinfected were not virally suppressed. This suggests ongoing sexual risk behaviors and the potential for HIV transmission among male syphilis cases.
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Technical assistance framework and activities, jurisdictions' experiences, and evaluation findings from the HRSA HAB Enhancing Linkage of STI and HIV Surveillance Data in the RWHAP SPNS initiative.
Resource (Conference Presentation) updated 09/14/2023
Results of SPNS evidence-based bacterial STI screening and testing interventions implemented in nine RWHAP-funded clinics in three jurisdictions with higher national incidence rates.
Resource (Conference Presentation) updated 09/14/2023
Review of challenges, facilitators, and best practices for routine screening, linkage, and rapid ART in two emergency departments, including during COVID-19.
Resource (Conference Presentation) updated 09/14/2023
Analysis of the costs of staff time to link HIV and STI surveillance data across four jurisdictions over a two-year period.
Resource (Conference Presentation) updated 09/14/2023
Overview of the policies, procedures, and protocols developed by an ADAP and Part C clinic to establish access to antiretrovirals, including long-acting cabotegravir/rilpivirine.
Resource (Conference Presentation) updated 09/14/2023